Efficacy and Safety of Laparoscopic Surgery in the Clinical Treatment of Gallstones and Cholangiolithiasis
Objective:To investigate the efficacy and safety of laparoscopic surgery in the clinical treatment of gallstones and cholangiolithiasis.Method:A total of 84 patients with gallstones and cholangiolithiasis treated in Zunyi Bozhou District People's Hospital from May 2022 to May 2023 were selected,and they were divided into two groups according to random number table method,with 42 patients in each group.The control group was treated with open surgery,and the observation group was treated with laparoscopic surgery.The surgical indicators,pain,white blood cell count,C-reactive protein,quality of life and complication rate were compared between the two groups.Result:The operative blood loss in the observation group was less than that in the control group,and the operation time,postoperative anal exhaust time,disappearance of abdominal pain and hospitalization time were shorter than those in the control group,the differences were statistically significant(P<0.05).At 1 d,3 d and 5 d after surgery,the visual analogue scale(VAS)score of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).At the 1 d and 3 d after surgery,the white blood cells and C-reactive protein in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The total incidence of complications in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).At 2 weeks,4 weeks,6 weeks and 8 weeks after surgery,the gastrointestinal quality of life index(GIQLI)score in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion:Laparoscopic surgery for the treatment of gallstones and cholangiolithiasis can relieve pain,reduce the incidence of complications and improve the quality of life of patients.
万方数据
维普
